The hPL-A promoter, including about 0.5 kb of upstream flanking DNA, will also direct hybrid reporter gene expression in transfected pituitary tumor cells in culture as effectively as equivalent hGH-N promoter sequences [12,45]. Here, GH1 is linked to pituitary tumor.